Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
2022 Ophthalmic Revenue Roundup for Sight Sciences, Iridex, LENSAR, and Three Others
Sight Sciences reported March 13 that it generated 2022 total revenue of $71.3 million, an increase of 46 percent over $49.0 million in 2021. Surgical glaucoma revenue in 2022 was $65.6 million, an...
AffaMed Gains Approval in Taiwan of Mini Well IOLs, Starts Trial in China
Shanghai-based AffaMed Technologies announced March 20 that the Taiwan Food and Drug Administration had approved the Mini Well, Mini Well Proxa, Mini Well Toric, and Mini 4 Ready intraocular lenses...
Cedars-Sinai Study Maps Retinal Changes that Correspond to Alzheimer’s
Investigators at Cedars-Sinai Medical Center in Los Angeles have analyzed changes in the retina and how they correspond to brain and cognitive changes in patients with Alzheimer’s disease. They say...
HCP Cureblindness Acquires SightLife International Program
HCP Cureblindness, formerly known as the Himalayan Cataract Project, reported March 16 that it would immediately acquire the SightLife International Program, the global division of Seattle-based Si...
Sight Sciences Launches Ergo-Series of OMNI Glaucoma Surgical System
Sight Sciences announced March 9 that it had launched the Ergo-Series of its OMNI glaucoma surgical system in the US. It is expected to be available outside the US later this year, the company said...
Maltese Patient Treated with ND1-LHON Gene Therapy Candidate Donated by Neurophth in China
Neurophth Therapeutics announced March 7 that a Maltese college student with ND1-associated Leber hereditary optic neuropathy (LHON) received treatment free of charge with the company’s investigati...
US FDA Gives Green Light to Phase II Study of Cognition’s Oral GA Candidate
Cognition Therapeutics announced March 15 that the US FDA had cleared its investigational new drug (IND) application for a Phase II study of CT1812 for geographic atrophy (GA) secondary to dry age-...
Abeona Therapeutics Unveils Three Retinal Gene Therapy Candidates
Abeona Therapeutics, of New York and Cleveland, unveiled on March 14 three preclinical gene therapy product candidates from its ophthalmology program. Abeona says ABO-504 is designed to reconstitut...
Ophthalmologists Upbeat at 2023 APAO Congress
An optimistic mood prevailed at the 38th congress of the Asia-Pacific Academy of Ophthalmology (APAO). It was not just because the meeting in Kuala Lumpur, Malaysia, was the first live meeting of t...
Ophthalmic Company Revenue Decreases 8.4 Percent in Fourth Quarter of 2022
Ophthalmic manufacturer revenue in Q4-2022 totaled $10.8 billion. Three public companies reported above-average revenue in Q4-2022 compared with the past three years, while 11 public companies had ...
Ophthalmologists Report Flat Growth in Q4-2022 Procedure Volume
US ophthalmologists reported that ophthalmic procedures grew 0.3 percent in Q4-2022 compared with the same quarter in 2021, according to Market Scope’s latest survey. Year-over-year performance var...
SVB has Been Lifeline for Small Innovative Ophthalmic Firms, Kliman Says
The loss of Silicon Valley Bank (SVB) as a lender would be a big blow for small, innovative ophthalmic companies that carry too much risk for a big bank, according to Gil Kliman, MD, a retina-train...
Past News Stories
Improved Vitrectomy System Features to Expand Retinal Treatments
Advancements in vitrectomy machine technology are expected to improve safety and efficacy and enable surgeons to reach a larger population of patients with retinal disease over the next five years....
J&J Vision Introduces a New Procedure for Lenticule Extraction
Johnson & Johnson Vision stepped into the lenticular extraction market in Asia at the 2023 APAO Congress in Kuala Lumpur with the introduction of the company’s new Elita femtosecond laser system an...
European Council Votes to Extend MDR Deadlines, Remove ‘Sell-Off’ Rule
The European Council voted unanimously March 7 to extend the transition period for medical devices under the Medical Devices Regulation (MDR) and to remove the sell-off provisions for existing prod...
Denmark’s Norlase Receives MDR Certification for its Line of Ophthalmic Lasers
Danish company Norlase announced Feb. 14 that its line of ophthalmic lasers had achieved EU MDR certification. Norlase markets the Leaf, a laser photocoagulator that mounts directly on a slit lamp;...
Remidio’s Medios AI for Smartphone DR Screening System Receives CE Marking
India-based Remidio announced Feb. 23 that it had received CE mark approval for its Medios AI, an algorithm that detects referable diabetic retinopathy (DR). The artificial intelligence system work...
Drugmaker Akorn Shuts Down US Sites, Lays Off Workforce
Akorn Pharmaceuticals shut down all its US sites on Feb. 23 and laid off its workforce, after recent financial and regulatory struggles. In an email to employees dated Feb. 22, the Gurnee, Illinois...
Select US FDA Approvals and Clearances in February 2023
The US FDA had two clearances through the ophthalmic device division using the 510(k) pathway in February 2023, according to the agency’s database. Phelcom Technologies gained market clearance for ...
US FDA Grants Premarket Approval to Bausch + Lomb’s StableVisc and TotalVisc OVDs
Bausch + Lomb received premarket approval (PMA) from the US FDA on Feb. 22 for its StableVisc (1.0% sodium hyaluronate) ophthalmic viscosurgical device (OVD) in cataract surgery. Concurrently, the ...
Genentech Breaks Ground on New Biologics Plant in California
Roche’s Genentech announced Feb. 10 that it had broken ground on a new biologics manufacturing facility at its Oceanside, California, campus, north of San Diego. The campus currently has seven buil...
Appasamy Owners Look to Sell Controlling Stake in Ophthalmic Company
The owners of Indian ophthalmic company Appasamy Associates plan to sell a controlling stake in the company and are in initial talks with private equity investors, The Economic Times of India repor...
Emerging Companies Pursuing Ophthalmic Indications, March 2023
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease. Company Location About NovelMed Therapeutics Cleveland, Ohio The company is developing NM308...
Novartis Shopping Drugs to Treat Front of Eye, Bloomberg Reports
Swiss drugmaker Novartis is working with an adviser to sell off its portfolio of front-of-the-eye treatments, including dry eye drug Xiidra, Bloomberg News reported March 14. Xiidra generated $487 ...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.